Top Institutions in Ophthalmology - Stem Cell Therapy for Retinal Degenerations
Leading institutions conduct translational and clinical research involving human embryonic stem cells (hESCs), induced pluripotent stem cells (iPSCs), and advanced genome editing techniques like CRISPR to develop and test RPE cell replacement therapies, often incorporating scaffold technologies and immunosuppression protocols to improve graft survival and function.
-
#1
University of Southern California (USC) Roski Eye Institute
Los Angeles, CA
USC Roski Eye Institute is a pioneer in clinical trials using hESC-derived RPE implants for AMD, with notable contributions from Dr. Mark Humayun in developing the CPCB-RPE1 implant and advancing surgical and immunosuppression protocols.
-
#2
Center for iPS Cell Research and Application (CiRA), Kyoto University
Kyoto, Japan
CiRA is internationally recognized for pioneering the use of autologous iPSC-derived RPE cell transplantation in patients with AMD, led by Dr. Masayo Takahashi and Dr. Shin-ichiro Handa, integrating genome editing and personalized regenerative therapies.
-
#3
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
Massachusetts Eye and Ear is a leading center for translational research in retinal degenerations, focusing on stem cell-derived RPE and photoreceptor replacement therapies, combining advanced imaging and surgical expertise to optimize clinical outcomes.
-
#4
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a strong research program in retinal stem cell therapies, focusing on both basic science and clinical translation, including the development of RPE replacement strategies and immunomodulatory approaches to enhance graft survival.